Alcon: turnover at 2.78 billion in the second quarter of 2026 (cross-border guide)

The Alcon ophthalmology group closed Q2 2026 with a turnover of 2.78 billion dollars, marking a growth of 8% on an annual basis.
Context
In a nutshell
- Q2 2026 turnover: 2.78 billion dollars.
- Growth on an annual basis: 8% (7% in local currencies).
- Operating margin (EBIT) up to 20.6%.
- Earnings per share rose to 84 cents.
Key facts
- What : Financial results for the second quarter of 2026
- When: Communicated after the closing of the Stock Exchange
- Where: Group headquarters (global market)
- Who: Alcon
- Amount: $2.78 billion in turnover
Alcon, a group specialised in the field of ophthalmological products, has announced its results for the second quarter of 2026. The company recorded a total turnover of 2.78 billion dollars, a figure that reflects a growth of 8% on an annual basis. Considering local currencies, the increase stands at 7%. The official statement, issued after the close of trading on the Stock Exchange according to the ATS agency, highlights a significant improvement in the main economic performance indicators.
Operational Analysis and Profitability
The operating margin, referred to as EBIT, reached 20.6% in the reference period, exceeding the 19.1% recorded in the same quarter of the previous year. At the same time, earnings per share increased to 84 cents compared to 76 cents in the second quarter of 2025. These results exceeded the expectations formulated by financial analysts, who had forecast more conservative figures in terms of margin and profit. Turnover, on the other hand, has
Operational details
2026 Financial Outlook and Scenarios
For the full 2026 fiscal year, Alcon's management has revised its earnings per share growth forecast upward, now estimating an increase between 12% and 15%, an improvement over the initial range of 10% to 13%. Expectations regarding the operating margin have also been adjusted upward: the company now anticipates an increase of 90-190 basis points, exceeding the previous guidance of 70-170 basis points. These updates provide investors and stakeholders with a more optimistic view of the group's ability to generate value, even within a competitive market environment. The confirmation of the revenue growth forecast between 5% and 7%, calculated at constant currencies, underscores the intention to maintain rigorous operational stability.
…
Key points
Monitoring procedure for investors and employees
For those wishing to delve into the impact of these results on their professional or financial situation, the first step is to consult the Alcon group's official investor relations portal to access the full quarterly reports. It is advisable to verify how projections on earnings per share and operating margins might influence long-term corporate investment plans, which could translate into new development opportunities or greater job stability. For employees in the sector, monitoring internal corporate communications regarding growth objectives is essential to align professional expectations. If one's role is influenced by market results, it is worth periodically analyzing the global economic situation through data provided by the FSO (Federal Statistical Office), which offers a clear picture of employment trends in Switzerland. For those managing a financial portfolio, it is advisable to compare the company's data with the historical performance of the ophthalmology sector, always keeping in mind the volatility of stock markets.
…
Frequently Asked Questions
- What was Alcon's revenue growth in Q2 2026?
- Alcon's turnover reached 2.78 billion dollars in the second quarter of 2026, registering an increase of 8% on an annual basis, which corresponds to a growth of 7% when calculated in local currencies.
- How did Alcon's earnings per share change from 2025?
- Alcon's earnings per share rose to 84 cents in the second quarter of 2026, an improvement over the 76 cents recorded in the same period of the previous year, the second quarter of 2025.
- What are the new growth forecasts for the full year 2026?
- For the year 2026, Alcon now expects earnings per share growth of between 12% and 15%, compared to the previous estimate of 10-13%. In addition, an improvement in operating margin of 90-190 basis points is expected, higher than the previous indication of 70-170 basis points.